Medicinal Chemistry - XXIst International Symposium 5-9 September 2010, Brussels, Belgium

被引:0
|
作者
Chan, Danny [1 ]
机构
[1] Thomson Reuters, London EC1N 8JS, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The XXIst International Symposium on Medicinal Chemistry from the European Federation of Medicinal Chemistry (EFMC-ISMC), held in Brussels, included topics covering new therapeutic developments in the field of medicinal research. This conference report highlights selected presentations on therapies for neuropathic pain, cognitive disorders, cancer and infection. Investigational drugs discussed include the anticancer imidazole derivative IRC-083927 (Ipsen), the HCV protease inhibitor TMC-435 (Tibotec Pharmaceuticals) and the tuberculosis therapy bedaquiline (Tibotec Pharmaceuticals).
引用
收藏
页码:749 / 752
页数:4
相关论文
共 50 条